Bariatric and Metabolic Surgery and Medical Insurance Payment in China
- PMID: 37474845
- DOI: 10.1007/s13679-023-00507-2
Bariatric and Metabolic Surgery and Medical Insurance Payment in China
Abstract
Purpose of review: This paper briefly introduces the status quo of bariatric and metabolic surgery and medical insurance payment in China.
Recent findings: Along with China's rapid economic growth, the prevalence of obesity and diabetes is increasing quickly. Because of their high body fat percentage and predominance of abdominal obesity, Chinese people experience metabolic disorders more frequently than Caucasians with the same BMI. Treatments are not medical because there is a lack of social understanding of obesity. Furthermore, obesity has not been accepted as a disease in China and so has not been included in the medical insurance payment system. Therefore, weight-loss medications are not covered by medical insurance. In China, bariatric and metabolic surgery have advanced for almost 20 years, and corresponding guidelines have been developed. However, there are regional and cognitive variations in whether medical insurance covers bariatric surgery or not. Recent research on the financial advantages of medical insurance coverage for weight-loss surgery showed that it conserves healthcare system resources. It will be important to raise public awareness regarding obesity in the future, present more evidence of the clinical efficacy of surgery, and work towards a higher percentage of medical insurance reimbursement for obesity treatment and bariatric surgery.
Keywords: Bariatric surgery; China; Diabetes mellitus; Medical insurance; Metabolic surgery; Obesity.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
-
- •• Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021 Jun;9(6):373–392. https://doi.org/10.1016/S2213-8587(21)00045-0 . Obesity has become a major public health issue in China. In view of the scarcity of research around the individual and collective roles of these upstream and downstream factors, multidisciplinary and transdisciplinary studies are urgently needed to identify systemic approaches that target both the population-level determinants and individual-level risk factors for obesity in China.
-
- Zhou BF. Cooperative meta-analysis group of the working group on obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002 Mar;15(1):83–96.
-
- • The Lancet Diabetes Endocrinology. Obesity in China: time to act. Lancet Diabetes Endocrinol. 2021 Jul;9(7):407. https://doi.org/10.1016/S2213-8587(21)00150-9 . China was once considered to have one of the leanest populations in the world. However, in the past 4 decades, the rates of overweight and obesity in China have rapidly increased, alongside with its fast economic growth, globalization, and urbanization.
-
- Hemmingsson E. The unparalleled rise of obesity in China: a call to action. Int J Obes (Lond). 2021;45(5):921–2. https://doi.org/10.1038/s41366-021-00774-w . - DOI - PubMed
-
- Wang D, Li Y, Lee SG, Wang L, Fan J, Zhang G, Wu J, Ji Y, Li S. Ethnic differences in body composition and obesity related risk factors: study in Chinese and white males living in China. PLoS One. 2011;6(5):e19835. https://doi.org/10.1371/journal.pone.0019835 .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials